No Data
Meinong Biology (301156.SZ): has cumulatively repurchased 1.48% of shares.
On December 2, GeLonghui reported that Meino Biological (301156.SZ) announced that as of November 29, 2024, the company had repurchased a total of 2,155,765 shares through a dedicated securities account for share buybacks via centralized bidding, accounting for 1.48% of the company's current share capital, with a highest fill price of 16.69 yuan/share, a lowest fill price of 10.73 yuan/share, and a total transaction amount of 30.29696 million yuan (excluding transaction fees).
Mei Nong Biological (301156.SZ): Plans to invest in a corn protein refined processing project with an annual output of 0.1 million tons.
Nov. 20th, Gelonghui: Meilon Biological (301156.SZ) announced that in order to improve the efficiency of the use of funds raised, fully consider the market environment and long-term planning, it plans to close the "Operation and Technical Service Center Construction" project, deduct the remaining funds of the "New Fodder-Related Product Production Project" and continue to invest the funds intended for paying part of the final payment by approximately 2.26 million yuan, as well as the balance of over-raised funds (including interest income and financial income) into the company's under-construction "Annual processing project for 0.1 million tons of corn protein", the investment amount of which is expected to be.
Weak Statutory Earnings May Not Tell The Whole Story For Shanghai Menon Animal Nutrition Technology (SZSE:301156)
Meinong Biology (301156.SZ): has repurchased 1.46% of its shares.
On November 1st, GeLongHui announced that as of October 31, 2024, the company has repurchased a total of 2,120,665 shares through the share repurchase special securities account in a centralized auction trading method, accounting for 1.46% of the company's current share capital. The highest fill price was 16.69 yuan per share, the lowest fill price was 10.73 yuan per share, and the total fill amount was 29.811 million yuan (excluding trading fees).
Mino Biotech: Report for the third quarter of 2024
Minnong Biological (301156.SZ): The net income for the first three quarters was 31.6116 million yuan, a year-on-year decrease of 36.49%.
Gelonghui October 29th | Meinong Biology (301156.SZ) announced its third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 0.34 billion yuan, a decrease of 9.19% year-on-year; net income attributable to shareholders of the listed company was 31.6116 million yuan, a decrease of 36.49% year-on-year; net income after deducting non-recurring gains and losses was 27.6796 million yuan, a decrease of 37.10% year-on-year; basic earnings per share were 0.2190 yuan per share.
Shanghai Menon Animal Nutrition Technology Co., Ltd. (SZSE:301156) Shares Fly 29% But Investors Aren't Buying For Growth
